Cargando…

Peroxisome proliferator‐activated receptor gamma coactivator 1‐alpha protects a fibrotic liver from partial hepatectomy‐induced advanced liver injury through regulating cell cycle arrest

BACKGROUND: A fibrotic liver may have an impaired regenerative capacity. Because liver transplantation is donor limited, understanding the regenerative ability of a fibrotic liver is important. METHODS: A two‐thirds partial hepatectomy (PH) was performed in C57Bl/6 mice with or without carbon tetrac...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Linzhong, Wang, Wei, Liu, Lipeng, Zhang, Yanghao, Zhang, Xiuying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300180/
https://www.ncbi.nlm.nih.gov/pubmed/34845850
http://dx.doi.org/10.1111/bcpt.13697
_version_ 1784751152930226176
author Zhang, Linzhong
Wang, Wei
Liu, Lipeng
Zhang, Yanghao
Zhang, Xiuying
author_facet Zhang, Linzhong
Wang, Wei
Liu, Lipeng
Zhang, Yanghao
Zhang, Xiuying
author_sort Zhang, Linzhong
collection PubMed
description BACKGROUND: A fibrotic liver may have an impaired regenerative capacity. Because liver transplantation is donor limited, understanding the regenerative ability of a fibrotic liver is important. METHODS: A two‐thirds partial hepatectomy (PH) was performed in C57Bl/6 mice with or without carbon tetrachloride (CCl(4)) treatment. Liver regeneration in the fibrotic liver after PH was assessed by the intrahepatic expression of the cell cycle regulators p53, p21, cyclin D1, c‐Fos and CDK2 using Western blot analysis. In addition, the expression of PGC‐1α and the cell proliferation‐related proteins PCNA and phosphate histone H3 was determined by Western blot and immunohistochemical staining analyses. Histone epigenetic modification of the PGC‐1α promoter was investigated through chromatin immunoprecipitation (ChIP) and reverse transcription–quantitative polymerase chain reaction (RT‐qPCR) assays. The impact of PGC‐1α on liver regeneration after PH was further evaluated in PGC‐1α‐knockout mice. RESULTS: A decreased expression of PGC‐1α and liver regeneration‐related genes in the fibrotic liver was detected after a PH. Histone acetylation at the PGC‐1α promoter led to increases in PGC‐1α expression and the survival rate in the fibrotic group after a PH. PGC‐1α‐mediated liver regeneration was further demonstrated in PGC‐1α(f/f)albcre(+/0) mice. CONCLUSION: Targeting PGC‐1α may represent a strategy to improve the treatment of PH in patients with liver fibrosis.
format Online
Article
Text
id pubmed-9300180
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93001802022-07-21 Peroxisome proliferator‐activated receptor gamma coactivator 1‐alpha protects a fibrotic liver from partial hepatectomy‐induced advanced liver injury through regulating cell cycle arrest Zhang, Linzhong Wang, Wei Liu, Lipeng Zhang, Yanghao Zhang, Xiuying Basic Clin Pharmacol Toxicol Basic Pharmacology BACKGROUND: A fibrotic liver may have an impaired regenerative capacity. Because liver transplantation is donor limited, understanding the regenerative ability of a fibrotic liver is important. METHODS: A two‐thirds partial hepatectomy (PH) was performed in C57Bl/6 mice with or without carbon tetrachloride (CCl(4)) treatment. Liver regeneration in the fibrotic liver after PH was assessed by the intrahepatic expression of the cell cycle regulators p53, p21, cyclin D1, c‐Fos and CDK2 using Western blot analysis. In addition, the expression of PGC‐1α and the cell proliferation‐related proteins PCNA and phosphate histone H3 was determined by Western blot and immunohistochemical staining analyses. Histone epigenetic modification of the PGC‐1α promoter was investigated through chromatin immunoprecipitation (ChIP) and reverse transcription–quantitative polymerase chain reaction (RT‐qPCR) assays. The impact of PGC‐1α on liver regeneration after PH was further evaluated in PGC‐1α‐knockout mice. RESULTS: A decreased expression of PGC‐1α and liver regeneration‐related genes in the fibrotic liver was detected after a PH. Histone acetylation at the PGC‐1α promoter led to increases in PGC‐1α expression and the survival rate in the fibrotic group after a PH. PGC‐1α‐mediated liver regeneration was further demonstrated in PGC‐1α(f/f)albcre(+/0) mice. CONCLUSION: Targeting PGC‐1α may represent a strategy to improve the treatment of PH in patients with liver fibrosis. John Wiley and Sons Inc. 2021-12-16 2022-02 /pmc/articles/PMC9300180/ /pubmed/34845850 http://dx.doi.org/10.1111/bcpt.13697 Text en © 2021 The Authors. Basic & Clinical Pharmacology & Toxicology published by John Wiley & Sons Ltd on behalf of Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society). https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Basic Pharmacology
Zhang, Linzhong
Wang, Wei
Liu, Lipeng
Zhang, Yanghao
Zhang, Xiuying
Peroxisome proliferator‐activated receptor gamma coactivator 1‐alpha protects a fibrotic liver from partial hepatectomy‐induced advanced liver injury through regulating cell cycle arrest
title Peroxisome proliferator‐activated receptor gamma coactivator 1‐alpha protects a fibrotic liver from partial hepatectomy‐induced advanced liver injury through regulating cell cycle arrest
title_full Peroxisome proliferator‐activated receptor gamma coactivator 1‐alpha protects a fibrotic liver from partial hepatectomy‐induced advanced liver injury through regulating cell cycle arrest
title_fullStr Peroxisome proliferator‐activated receptor gamma coactivator 1‐alpha protects a fibrotic liver from partial hepatectomy‐induced advanced liver injury through regulating cell cycle arrest
title_full_unstemmed Peroxisome proliferator‐activated receptor gamma coactivator 1‐alpha protects a fibrotic liver from partial hepatectomy‐induced advanced liver injury through regulating cell cycle arrest
title_short Peroxisome proliferator‐activated receptor gamma coactivator 1‐alpha protects a fibrotic liver from partial hepatectomy‐induced advanced liver injury through regulating cell cycle arrest
title_sort peroxisome proliferator‐activated receptor gamma coactivator 1‐alpha protects a fibrotic liver from partial hepatectomy‐induced advanced liver injury through regulating cell cycle arrest
topic Basic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300180/
https://www.ncbi.nlm.nih.gov/pubmed/34845850
http://dx.doi.org/10.1111/bcpt.13697
work_keys_str_mv AT zhanglinzhong peroxisomeproliferatoractivatedreceptorgammacoactivator1alphaprotectsafibroticliverfrompartialhepatectomyinducedadvancedliverinjurythroughregulatingcellcyclearrest
AT wangwei peroxisomeproliferatoractivatedreceptorgammacoactivator1alphaprotectsafibroticliverfrompartialhepatectomyinducedadvancedliverinjurythroughregulatingcellcyclearrest
AT liulipeng peroxisomeproliferatoractivatedreceptorgammacoactivator1alphaprotectsafibroticliverfrompartialhepatectomyinducedadvancedliverinjurythroughregulatingcellcyclearrest
AT zhangyanghao peroxisomeproliferatoractivatedreceptorgammacoactivator1alphaprotectsafibroticliverfrompartialhepatectomyinducedadvancedliverinjurythroughregulatingcellcyclearrest
AT zhangxiuying peroxisomeproliferatoractivatedreceptorgammacoactivator1alphaprotectsafibroticliverfrompartialhepatectomyinducedadvancedliverinjurythroughregulatingcellcyclearrest